Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case–control study

Abstract

IgAN patients with pathological assessment of M1, low baseline eGFR, TA-Hb and high TA-UA were more likely to progress to ESRD, and should be paid more attention. Appropriate regulations of UA, Hb and urine protein after diagnose may be a promising treatment.